We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 21-40 of 10,000 results
  1. Considerations for the optimization of in vitro models of chloropicrin toxicity

    Chloropicrin (CP) is a common agricultural fumigant historically used as a chemical warfare agent and is a concern for potential use in warfare and...

    Bailey T. Chalmers, Abigail F. Merriman, Albert L. Ruff in Archives of Toxicology
    Article 03 November 2022
  2. Solar Radiation and Phototoxicity of Cosmetics: Avenues of In Vitro Skin Models

    Skin is the body’s largest organ, performing several critical functions, including photoprotection and thermoregulation. The skin comprises three...
    Mohd. Danish Kamar, Madhu Bala, ... Saroj Kumar Amar in Skin 3-D Models and Cosmetics Toxicity
    Chapter 2023
  3. Complex in vitro models: do not complicate it

    J. Miguel Oliveira in In vitro models
    Article 01 August 2023
  4. The development of in vitro organotypic 3D vulvar models to study tumor-stroma interaction and drug efficacy

    Background

    Vulvar squamous cell carcinoma (VSCC) is a rare disease with a poor prognosis. To date, there’s no proper in vitro modeling system for VSCC...

    Shidi Wu, Bertine W. Huisman, ... Abdoelwaheb El Ghalbzouri in Cellular Oncology
    Article 07 December 2023
  5. Skeletal Muscle Satellite Cell Physiology and Function: Complimentary In Vitro and In Vivo Models and Methods

    Skeletal muscle is a highly adaptable tissue, displaying features of hypertrophy (growth) and atrophy (loss), as a result of both internal and...
    Mark Viggars, Andy Nolan, ... Claire Stewart in Neuromuscular Assessments of Form and Function
    Protocol 2023
  6. Optimize and Strengthen Machine Learning Models Based on in Vitro Assays with Mechanistic Knowledge and Real-World Data

    The rapid development of in vitro assays for toxicity assessment has provided a tremendous opportunity to improve toxicity risk assessment by...
    Thilini V. Mahanama, Arpan Biswas, Dong Wang in Machine Learning and Deep Learning in Computational Toxicology
    Chapter 2023
  7. Empagliflozin attenuates intestinal inflammation through suppression of nitric oxide synthesis and myeloperoxidase activity in in vitro and in vivo models of colitis

    Inflammatory bowel diseases (IBD) are characterized by chronic and relapsing inflammation affecting the gastrointestinal (GI) tract. The incidence...

    Adam Makaro, Mikołaj Świerczyński, ... Maciej Salaga in Inflammopharmacology
    Article Open access 22 April 2023
  8. Tumor Models of Retinoblastoma: In Vivo, Ex Vivo, and In Vitro Models

    In the initial simplistic understanding, childhood retinal cancer retinoblastoma is due to the defect in the retinoblastoma gene. However, the deep...
    Raaghav Sen, Neethi Chandra Thathapudi, ... Jaganmohan Reddy Jangamreddy in Handbook of Animal Models and its Uses in Cancer Research
    Living reference work entry 2022
  9. Towards in vitro models for reducing or replacing the use of animals in drug testing

    David M. Stresser, Anna K. Kopec, ... Kimberly A. Homan in Nature Biomedical Engineering
    Article 27 December 2023
  10. Glabridin reduces neuroinflammation by modulating inflammatory signals in LPS-induced in vitro and in vivo models

    Objectives

    Chronic neuroinflammation has become one of the important causes of common neurodegeneration disease. Therefore, the target of this study...

    Jiyu Weng, Ying Wang, ... Zhiyun Du in Inflammopharmacology
    Article 19 February 2024
  11. In vitro assessment of thyroid peroxidase inhibition by chemical exposure: comparison of cell models and detection methods

    Disruption of the thyroid hormone (TH) system is connected with diverse adverse health outcomes in wildlife and humans. It is crucial to develop and...

    Runze Liu, Jiří Novák, Klára Hilscherová in Archives of Toxicology
    Article Open access 25 May 2024
  12. In Vitro and In Vivo Models for Metastatic Intestinal Tumors Using Genotype-Defined Organoids

    It has been established that the accumulation of driver gene mutations causes malignant progression of colorectal cancer (CRC) through positive...
    Atsuya Morita, Mizuho Nakayama, ... Masanobu Oshima in Inflammation and Cancer
    Protocol 2023
  13. Activation of HCA2 regulates microglial responses to alleviate neurodegeneration in LPS-induced in vivo and in vitro models

    Background

    Previous studies have shown a close association between an altered immune system and Parkinson's disease (PD). Neuroinflammation inhibition...

    Dewei He, Shoupeng Fu, ... Dianfeng Liu in Journal of Neuroinflammation
    Article Open access 29 March 2023
  14. Cell-Based Intestinal In Vitro Models for Drug Absorption Screening

    Despite major innovations in drug administration, oral intake remains the preferred route for drug delivery, mainly due to ease of administration and...
    Hugo Almeida, Amélia C. F. Vieira, ... Bruno Sarmento in Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays
    Living reference work entry 2022
  15. In Vitro Models of Astrocytes: An Overview

    Astrocytes are the most abundant cell type in the brain. In recent years, astrocytes have been demonstrated to be important for the physiological...
    Pallavi Pant, Guneet Kaur, Pankaj Seth in The Biology of Glial Cells: Recent Advances
    Chapter 2022
  16. Studying Angiogenesis Using Matrigel In Vitro and In Vivo

    Angiogenesis plays a critical role in physiology and pathophysiology of the human body; hence, it is important to explore the methods to study...
    Anantha K. Kanugula, Ravi K. Adapala, ... Charles K. Thodeti in Vascular Hyperpermeability
    Protocol 2024
  17. Transcriptomic-based evaluation of trichloroethylene glutathione and cysteine conjugates demonstrate phenotype-dependent stress responses in a panel of human in vitro models

    Environmental or occupational exposure of humans to trichloroethylene (TCE) has been associated with different extrahepatic toxic effects, including...

    Liliana Capinha, Yaran Zhang, ... Paul Jennings in Archives of Toxicology
    Article Open access 28 December 2022
  18. Next-generation in vitro blood–brain barrier models: benchmarking and improving model accuracy

    With the limitations associated with post-mortem tissue and animal models, In vitro BBB models enable precise control of independent variables and...

    Raleigh M. Linville, Peter C. Searson in Fluids and Barriers of the CNS
    Article Open access 07 December 2021
  19. Towards best use and regulatory acceptance of generic physiologically based kinetic (PBK) models for in vitro-to-in vivo extrapolation (IVIVE) in chemical risk assessment

    With an increasing need to incorporate new approach methodologies (NAMs) in chemical risk assessment and the concomitant need to phase out animal...

    Abdulkarim Najjar, Ans Punt, ... Nynke I. Kramer in Archives of Toxicology
    Article Open access 05 September 2022
  20. Validating MRI-Derived Myocardial Stiffness Estimates Using In Vitro Synthetic Heart Models

    Impaired cardiac filling in response to increased passive myocardial stiffness contributes to the pathophysiology of heart failure. By leveraging...

    Fikunwa O. Kolawole, Mathias Peirlinck, ... Daniel B. Ennis in Annals of Biomedical Engineering
    Article 13 March 2023
Did you find what you were looking for? Share feedback.